BIG
BCYC

Brooklyn Investment Group’s Bicycle Therapeutics BCYC Stock Holding History

Brooklyn Investment Group’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,216
Closed -$69.3K – 1857
2025
Q4 		$69.3K Buy
+10,216
New +$75.3K ﹤0.01% 1483
2025
Q3 		– Sell
-923
Closed -$6.42K – 880
2025
Q2 		$6.42K Buy
+923
New +$7.35K ﹤0.01% 2378

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Brooklyn Investment Group's BCYC Position: Q1 2026 in Review

Brooklyn Investment Group sold out of Bicycle Therapeutics (BCYC) in Q1 2026, closing a stake of 10,216 shares — an estimated $69.3K sold.

Brooklyn Investment Group first reported a position in BCYC in Q2 2025 and held it in 2 quarters. The position peaked at $69.3K in Q4 2025. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Brooklyn Investment Group reported no remaining Bicycle Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Brooklyn Investment Group sold 10,216 Bicycle Therapeutics shares in Q1 2026, an estimated $69.3K.
  • Brooklyn Investment Group first reported a position in Bicycle Therapeutics in Q2 2025 and held it in 2 quarters.
  • Brooklyn Investment Group's Bicycle Therapeutics position peaked at $69.3K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.